Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation

Abstract
NIHR Journals Library Background: The National Institute for Health and Clinical Excellence (NICE) was reviewing its previous guidance on continuous subcutaneous insulin infusion (CSII). The review provided an assessment of evidence which had been published since the previous NICE appraisal (TA 151) in 2007. The National Institute for Health and Clinical Excellence (NICE) was reviewing
Funding Information
  • Health Technology Assessment Programme (06/61/01)

This publication has 63 references indexed in Scilit: